G2P

Serial Number 76131418
606

Registration Progress

Application Filed
Sep 19, 2000
Under Examination
Oct 9, 2001
Approved for Publication
Jul 4, 2001
Published for Opposition
Jul 17, 2001
Registered

Trademark Image

G2P

Basic Information

Serial Number
76131418
Filing Date
September 19, 2000
Published for Opposition
July 17, 2001
Abandonment Date
October 10, 2003
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 10, 2003
Classes
005

Rights Holder

Millennium Pharmaceuticals, Inc.

03
Address
75 Sidney Street
Cambridge, MA 02138

Ownership History

Millennium Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Millennium Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Michael J. Bevilacqua

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

17 events
Date Code Type Description Documents
Dec 11, 2003 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 13, 2003 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 7, 2003 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 7, 2003 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 22, 2002 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 4, 2002 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 4, 2002 EXT2 S SOU EXTENSION 2 FILED Loading...
May 7, 2002 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 15, 2002 MAIL I PAPER RECEIVED Loading...
Apr 9, 2002 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 9, 2001 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 17, 2001 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 4, 2001 NPUB O NOTICE OF PUBLICATION Loading...
Feb 20, 2001 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 7, 2001 CNEA F EXAMINER'S AMENDMENT MAILED Loading...
Feb 1, 2001 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 31, 2001 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
diagnostic assays for diagnostic and therapeutic clinical medical use; diagnostic assay kits containing nucleic acid and/or antibody reagents for diagnosing diseases and providing genomic and proteomic profiles useful in the selection of therapeutics for clinical medical use
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005